Education and Training
- M.S., University of North Carolina at Chapel Hill, 1979
- B.S., East Carolina University, 1977
Singh, Sheena D., Nicole Robbins, Aimee K. Zaas, Wiley A. Schell, John R. Perfect, and Leah E. Cowen. “Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.” Plos Pathog 5, no. 7 (July 2009): e1000532. https://doi.org/10.1371/journal.ppat.1000532.
Cowen, Leah E., Sheena D. Singh, Julia R. Köhler, Cathy Collins, Aimee K. Zaas, Wiley A. Schell, Hamza Aziz, et al. “Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease.” Proc Natl Acad Sci U S A 106, no. 8 (February 24, 2009): 2818–23. https://doi.org/10.1073/pnas.0813394106.
Onyewu, Chiatogu, Emily Eads, Wiley A. Schell, John R. Perfect, Yehuda Ullmann, Gil Kaufman, Benjamin A. Horwitz, Israela Berdicevsky, and Joseph Heitman. “Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection model.” Antimicrob Agents Chemother 51, no. 10 (October 2007): 3743–46. https://doi.org/10.1128/AAC.00492-07.
Espinel-Ingroff, A., A. Fothergill, M. Ghannoum, E. Manavathu, L. Ostrosky-Zeichner, M. A. Pfaller, M. G. Rinaldi, W. Schell, and T. J. Walsh. “Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds.” J Clin Microbiol 45, no. 7 (July 2007): 2180–82. https://doi.org/10.1128/JCM.00399-07.
Smith, P. B., W. J. Steinbach, C. M. Cotten, W. A. Schell, J. R. Perfect, T. J. Walsh, and D. K. Benjamin. “Caspofungin for the treatment of azole resistant candidemia in a premature infant.” Journal of Perinatology : Official Journal of the California Perinatal Association 27, no. 2 (February 2007): 127–29. https://doi.org/10.1038/sj.jp.7211637.
Guarro, Josep, Luiz Carlos Severo, Josepa Gené, Flavio de Mattos Oliveira, Josep Cano, Guilherme Franche, Vlademir Vicente Cantarelli, and Wiley A. Schell. “Sinusitis caused by the fungus Xylaria enteroleuca in a lung transplant recipient.” Diagn Microbiol Infect Dis 56, no. 2 (October 2006): 207–12. https://doi.org/10.1016/j.diagmicrobio.2006.06.002.
Espinel-Ingroff, A., A. Fothergill, M. Ghannoum, E. Manavathu, L. Ostrosky-Zeichner, M. Pfaller, M. Rinaldi, W. Schell, and T. Walsh. “Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.” J Clin Microbiol 43, no. 10 (October 2005): 5243–46. https://doi.org/10.1128/JCM.43.10.5243-5246.2005.
Alexander, Barbara D., Wiley A. Schell, Jackie L. Miller, Gwynn D. Long, and John R. Perfect. “Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole.” Transplantation 80, no. 6 (September 27, 2005): 868–71. https://doi.org/10.1097/01.tp.0000173771.47698.7b.
Chang, Christopher Y., Wiley A. Schell, John R. Perfect, and Gregory F. Hulka. “Novel use of a swimming pool biocide in the treatment of a rare fungal mastoiditis.” Laryngoscope 115, no. 6 (June 2005): 1065–69. https://doi.org/10.1097/01.MLG.0000163338.45700.FE.